{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:42:58Z","timestamp":1790700178963,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.cca.2024.119873","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T14:39:15Z","timestamp":1721054355000},"page":"119873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Serum metabolomic profile of myasthenia gravis and potential values as biomarkers in disease monitoring"],"prefix":"10.1016","volume":"562","author":[{"given":"Qianqian","family":"Sha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailian","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cca.2024.119873_b0005","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/jama.2023.16872","article-title":"What is myasthenia gravis?","volume":"331","author":"Marcus","year":"2024","journal-title":"J. Am. Med. Assoc."},{"issue":"5","key":"10.1016\/j.cca.2024.119873_b0010","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S1474-4422(23)00125-4","article-title":"New therapies for autoimmune myasthenia gravis","volume":"22","author":"Verschuuren","year":"2023","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.cca.2024.119873_b0015","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"issue":"26","key":"10.1016\/j.cca.2024.119873_b0020","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.cca.2024.119873_b0025","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1474-4422(21)00297-0","article-title":"Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders","volume":"21","author":"Punga","year":"2022","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.cca.2024.119873_b0030","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/BOR.0000000000000647","article-title":"Diagnosis and treatment of myasthenia gravis","volume":"31","author":"Mantegazza","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.cca.2024.119873_b0035","doi-asserted-by":"crossref","unstructured":"D.B. Sanders, T.M. Burns, G.R. Cutter, J.M. Massey, V.C. Juel, L. Hobson-Webb, G. Muscle Study, Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis?, Muscle Nerve 49(4) (2014) 483-486.","DOI":"10.1002\/mus.23944"},{"key":"10.1016\/j.cca.2024.119873_b0040","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jneuroim.2018.05.003","article-title":"Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis","volume":"321","author":"Sabre","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cca.2024.119873_b0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cbpa.2016.12.006","article-title":"Frontiers of high-throughput metabolomics","volume":"36","author":"Zampieri","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"1","key":"10.1016\/j.cca.2024.119873_b0050","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s12967-019-2096-8","article-title":"Metabolic signature of obesity-associated insulin resistance and type 2 diabetes","volume":"17","author":"Al-Sulaiti","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cca.2024.119873_b0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/bs.acc.2018.02.002","article-title":"Metabolomics and lipidomics of ischemic stroke","volume":"85","author":"Au","year":"2018","journal-title":"Adv. Clin. Chem."},{"issue":"2","key":"10.1016\/j.cca.2024.119873_b0060","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s12035-021-02657-7","article-title":"Review of metabolomics-based biomarker research for Parkinson's disease","volume":"59","author":"Li","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.cca.2024.119873_b0065","article-title":"Metabolomics in rheumatoid arthritis: advances and review","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2024.119873_b0070","doi-asserted-by":"crossref","unstructured":"M. Sengupta, A. Cheema, H.J. Kaminski, L.L. Kusner, G. Muscle Study, Serum metabolomic response of myasthenia gravis patients to chronic prednisone treatment, PLoS One 9(7) (2014) e102635.","DOI":"10.1371\/journal.pone.0102635"},{"issue":"8","key":"10.1016\/j.cca.2024.119873_b0075","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11306-019-1571-9","article-title":"Beyond the antibodies: serum metabolomic profiling of myasthenia gravis","volume":"15","author":"Blackmore","year":"2019","journal-title":"Metabolomics"},{"key":"10.1016\/j.cca.2024.119873_b0080","doi-asserted-by":"crossref","unstructured":"B. Shen, X. Yi, Y. Sun, X. Bi, J. Du, C. Zhang, S. Quan, F. Zhang, R. Sun, L. Qian, W. Ge, W. Liu, S. Liang, H. Chen, Y. Zhang, J. Li, J. Xu, Z. He, B. Chen, J. Wang, H. Yan, Y. Zheng, D. Wang, J. Zhu, Z. Kong, Z. Kang, X. Liang, X. Ding, G. Ruan, N. Xiang, X. Cai, H. Gao, L. Li, S. Li, Q. Xiao, T. Lu, Y. Zhu, H. Liu, H. Chen, T. Guo, Proteomic and Metabolomic Characterization of COVID-19 Patient Sera, Cell 182(1) (2020) 59-72 e15.","DOI":"10.1016\/j.cell.2020.05.032"},{"issue":"3","key":"10.1016\/j.cca.2024.119873_b0085","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1212\/WNL.0000000000011124","article-title":"International consensus guidance for management of myasthenia gravis: 2020 update","volume":"96","author":"Narayanaswami","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.cca.2024.119873_b0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/joim.12163","article-title":"Pathogenic immune mechanisms at the neuromuscular synapse: the role of specific antibody-binding epitopes in myasthenia gravis","volume":"275","author":"Huijbers","year":"2014","journal-title":"J. Intern. Med."},{"issue":"5","key":"10.1016\/j.cca.2024.119873_b0095","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1586\/eci.12.34","article-title":"Muscle autoantibodies in myasthenia gravis: beyond diagnosis?","volume":"8","author":"Meriggioli","year":"2012","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"4","key":"10.1016\/j.cca.2024.119873_b0100","doi-asserted-by":"crossref","first-page":"E253","DOI":"10.1152\/ajpendo.00331.2016","article-title":"Overexpression of PGC-1alpha increases peroxisomal activity and mitochondrial fatty acid oxidation in human primary myotubes","volume":"312","author":"Huang","year":"2017","journal-title":"Am. J. Phys. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.cca.2024.119873_b0105","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1210\/jc.2002-020440","article-title":"Muscle uridine diphosphate-hexosamines do not decrease despite correction of hyperglycemia-induced insulin resistance in type 2 diabetes","volume":"87","author":"Pouwels","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.cca.2024.119873_b0110","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1074\/jbc.272.8.4889","article-title":"The tissue concentration of UDP-N-acetylglucosamine modulates the stimulatory effect of insulin on skeletal muscle glucose uptake","volume":"272","author":"Hawkins","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.cca.2024.119873_b0115","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00109-020-01925-8","article-title":"Impact of beta-glycerophosphate on the bioenergetic profile of vascular smooth muscle cells","volume":"98","author":"Alesutan","year":"2020","journal-title":"J. Mol. Med. (Berl)"},{"issue":"5","key":"10.1016\/j.cca.2024.119873_b0120","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00415-010-5823-x","article-title":"Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies","volume":"258","author":"Cenacchi","year":"2011","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.cca.2024.119873_b0125","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2990.2008.00965.x","article-title":"Muscle histopathology in myasthenia gravis with antibodies against MuSK and AChR","volume":"35","author":"Martignago","year":"2009","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.cca.2024.119873_b0130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.nutr.25.050304.092610","article-title":"Fatty acids as modulators of the immune response","volume":"26","author":"Fritsche","year":"2006","journal-title":"Annu. Rev. Nutr."},{"issue":"24","key":"10.1016\/j.cca.2024.119873_b0135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249628","article-title":"The role of arachidonic and linoleic acid derivatives in pathological pregnancies and the human reproduction process","volume":"21","author":"Szczuko","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cca.2024.119873_b0140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12974-023-02981-w","article-title":"Arachidonic acid-derived lipid mediators in multiple sclerosis pathogenesis: fueling or dampening disease progression?","volume":"21","author":"Broos","year":"2024","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.cca.2024.119873_b0145","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrrheum.2014.2","article-title":"The skeletal muscle arachidonic acid cascade in health and inflammatory disease","volume":"10","author":"Korotkova","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.cca.2024.119873_b0150","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1084\/jem.193.2.255","article-title":"Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2","volume":"193","author":"Hirai","year":"2001","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.cca.2024.119873_b0155","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/j.1365-2222.2004.02027.x","article-title":"Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells\/DP2","volume":"34","author":"Yoshimura-Uchiyama","year":"2004","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.cca.2024.119873_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113700","article-title":"Arachidonic acid inhibition of the NLRP3 inflammasome is a mechanism to explain the anti-inflammatory effects of fasting","volume":"43","author":"Pereira","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.cca.2024.119873_b0165","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.biocel.2016.08.012","article-title":"Cessation of biomechanical stretch model of C2C12 cells models myocyte atrophy and anaplerotic changes in metabolism using non-targeted metabolomics analysis","volume":"79","author":"Ilaiwy","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"7","key":"10.1016\/j.cca.2024.119873_b0170","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1017\/S000711451600297X","volume":"116","author":"Wang","year":"2016","journal-title":"Br. J. Nutr."},{"issue":"3","key":"10.1016\/j.cca.2024.119873_b0175","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1080\/15548627.2022.2098452","article-title":"Current opinions on mitophagy in fungi","volume":"19","author":"Shen","year":"2023","journal-title":"Autophagy"},{"issue":"Pt 15","key":"10.1016\/j.cca.2024.119873_b0180","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1242\/jcs.126128","article-title":"The LIR motif - crucial for selective autophagy","volume":"126","author":"Birgisdottir","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.cca.2024.119873_b0185","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jmb.2016.02.004","article-title":"Mechanisms of selective autophagy","author":"Zaffagnini","year":"2016","journal-title":"J Mol Biol 428(9 Pt a)"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124021260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124021260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T08:52:01Z","timestamp":1723539121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898124021260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":37,"alternative-id":["S0009898124021260"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2024.119873","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum metabolomic profile of myasthenia gravis and potential values as biomarkers in disease monitoring","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2024.119873","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119873"}}